dilazep has been researched along with Glomerulonephritis in 6 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of the present study was to compare the effects of imidapril hydrochloride, an angiotensin converting enzyme inhibitor, and dilazep hydrochloride, an antiplatelet agent, on urinary protein excretion and renal function in patients with chronic glomerulonephritis." | 7.73 | Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis. ( Hayakawa, H; Hirata, Y; Kamijo, A; Kimura, K; Nagata, D; Nishimatsu, H; Oba, S; Satonaka, H; Suzuki, E; Takahashi, M; Takeda, R; Yamamoto, Y, 2005) |
| "The objective of the present study was to compare the effects of imidapril hydrochloride, an angiotensin converting enzyme inhibitor, and dilazep hydrochloride, an antiplatelet agent, on urinary protein excretion and renal function in patients with chronic glomerulonephritis." | 3.73 | Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis. ( Hayakawa, H; Hirata, Y; Kamijo, A; Kimura, K; Nagata, D; Nishimatsu, H; Oba, S; Satonaka, H; Suzuki, E; Takahashi, M; Takeda, R; Yamamoto, Y, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satonaka, H | 1 |
| Suzuki, E | 1 |
| Hayakawa, H | 1 |
| Nishimatsu, H | 1 |
| Nagata, D | 1 |
| Oba, S | 1 |
| Kamijo, A | 1 |
| Takeda, R | 1 |
| Takahashi, M | 1 |
| Yamamoto, Y | 1 |
| Kimura, K | 1 |
| Hirata, Y | 1 |
| Morozumi, K | 2 |
| Sohmiya, S | 1 |
| Kobayashi, M | 1 |
| Sato, M | 1 |
| Fujinami, T | 1 |
| Yoshida, A | 1 |
| Gotoh, I | 1 |
| Nakazawa, K | 1 |
| Moriya, T | 1 |
| Kasai, S | 1 |
| Yamazaki, T | 1 |
| Komiyama, Y | 1 |
| Shigematsu, H | 1 |
| Akiba, T | 1 |
| Koga, T | 1 |
| Gohda, T | 1 |
| Makita, Y | 1 |
| Shike, T | 1 |
| Funabiki, K | 1 |
| Horikoshi, S | 1 |
| Shirato, I | 1 |
| Tomino, Y | 1 |
| Haramaki, R | 1 |
| Tamaki, K | 1 |
| Fujisawa, M | 1 |
| Ikedo, H | 1 |
| Haramaki, N | 1 |
| Okuda, S | 1 |
| Takasaki, H | 1 |
| Shibata, M | 1 |
| Ito, S | 1 |
| Kida, H | 1 |
| Iwata, J | 1 |
1 trial available for dilazep and Glomerulonephritis
| Article | Year |
|---|---|
Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
Topics: Adolescent; Adult; Dilazep; Female; Glomerulonephritis; Glomerulonephritis, IGA; Humans; Immunohisto | 2001 |
5 other studies available for dilazep and Glomerulonephritis
| Article | Year |
|---|---|
Long-term effect of imidapril hydrochloride compared with dilazep hydrochloride administration on blood pressure and renal function in patients with chronic glomerulonephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Dilazep; Drug Ther | 2005 |
[Clinical effects of dilazep dihydrochloride on glomerulonephritis].
Topics: Adult; Aged; Azepines; Chronic Disease; Dilazep; Female; Glomerulonephritis; Hematuria; Humans; Male | 1983 |
Dilazep prevents glomerulosclerosis in accelerated Masugi nephritis in the rat.
Topics: Animals; Dilazep; Disease Models, Animal; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; K | 1993 |
Effect of dilazep hydrochloride, an antiplatelet agent, on the proliferation of cultured mouse glomerular mesangial cells.
Topics: Animals; Blood Platelets; Cell Division; Cells, Cultured; Dilazep; Glomerular Mesangium; Glomerulone | 2000 |
[Long-term effect of dilazep therapy in patients with chronic glomerulonephritis and nephrotic syndrome].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azepines; Child; Child, Preschool; Chronic Disease; Dila | 1987 |